We're working on something new at CrunchBase. Edits have been disabled for a few days, but you can still contact us for urgent changes.
Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Funds

Total$630M
Burrill Capital Fund IV, 8/2012 $505M
Burrill Brazil Fund I, 1/2012 $125M

Offices

Headquarters
One Embarcadero Center
Suite 2700
San Francisco, CA, 94111
USA

People

Founder & CEO
Venture Partner
Venture Partner
Managing Director
Managing Director
Managing Director
Managing Director
Managing Director
Show All People

Tags

Burrill & Company

Burrill & Company invests in life science companies whose technologies and products are applicable across a wide range of life science sub-sectors: human healthcare therapeutics and diagnostics/devices; health/wellness; agricultural biotechnology; biofuels, and industrial biotechnology (biomaterials/bioprocesses).

Recent Milestones

Investments

Company Date Round Size Participants
Nora Therapeutics 4/2014Series B$18M5
Neos Therapeutics 3/2014Series C$15.5M4
Catalyst Biosciences 4/2013Venture Round$5.07M6
BetterDoctor 3/2013Seed$2.6M6
Odyssey Thera 2/2013Venture Round$2.8M3
MabVax Therapeutics 11/2012Series B$5.25M2
Cobalt Technologies 10/2012Venture Round$4.98M3
Catalyst Biosciences 9/2012Partial Close$13.4M5
AliveCor 6/2012Series B$10.5M4
Ceptaris Therapeutics 6/2012Series D$10M6
WhiteGlove Health 4/2012Series E$12.9M1
Cobalt Technologies 4/2012Venture Round$2.92M5
Virdia 3/2012Venture Round$20M3
Yaupon Therapeutics 8/2011Series D$14.4M4
AliveCor 8/2011Series A$3M3
NewBridge Pharmaceuticals 9/2010Series B$12M2
FerroKin Biosciences 6/2010Series B$12M5
Endocyte 1/2010Series C$26M5
PrimeraDx (Primera Biosystems) 10/2009Series C$20M6
XDx 10/2009Venture Round$14.4M7
Gevo 8/2009Venture Round$40M7
XDx 8/2009Series F$14.4M8
Virdia 6/2009Series A$5.5M2
Aerovance 4/2009Venture Round$38M8
Catalyst Biosciences 12/2008Series C$40M7
Gevo 5/2008Series C$17M4
NanoVasc 3/2008Series A$4.7M2
Light Sciences Oncology 7/2007Series B$30M5
Aerovance 3/2007Series C$60M6
diaDexus 1/2007Series E$40M7
Neurotech 11/2006Series B$35M12
Sciona 4/2006Series C$9.9M5
Chromatin 4/2006Venture Round$1.6M4
Catalyst Biosciences 2/2006Series B$30M6
Adlyfe 1/2006Series A$3.3M2
XDx 1/2006Venture Round$26.5M7
Chlorogen 8/2005Series B$6M4

Videos

Sources

  1. Burrill & Co. Closes Fourth Life Sciences Fund at $505M (pevc.dowjones.com) [edit]
  2. Burrill & Co. Holds First Close of Brazil Fund at $125M (finsmes.com) [edit]
  3. Nora Therapeutics Announces $18 Million Series B Financing (prnewswire.com) [edit]
  4. Neos Therapeutics Raises $15.5M in Series C Financing (finsmes.com) [edit]
  5. VC Funding: Q2 2013 source [edit]
  6. With $2.6M From SoftTech, 500 Startups & More, BetterDoctor Wants To Take The Pain Out Of Finding The Best Local Care (techcrunch.com) [edit]
  7. Odyssey Thera Finds $2.8M and Merck Research Contract (pevc.dowjones.com) [edit]
  8. MabVax Therapeutics Closes $5.25M in Series B Financing (finsmes.com) [edit]
  9. VC funding: Q4 2012 [edit]
  10. SEC (sec.gov) [edit]
  11. AliveCor Raises $10.5M in Series B Financing (in.finance.yahoo.com) [edit]
  12. Ceptaris Therapeutics Raises $10M in Series D-1 Funding (finsmes.com) [edit]
  13. WhiteGlove Health Closes Funding Round (whiteglove.com) [edit]
  14. VC Funding: Q2 2012 source [edit]
  15. Officially Announces the Closing of $30 Million in Private Financing (virdia.com) [edit]
  16. Yaupon Therapeutics Raises $14.4M in Series D Funding (finsmes.com) [edit]
  17. AliveCor Turns Mobile Devices Into Low-Cost Heart Monitors, Raises $3 Million (techcrunch.com) [edit]
  18. NewBridge Pharmaceuticals Raises $12M in Series B Financing (finsmes.com) [edit]
  19. FerroKin rounds up $12M for iron overload treatment Read more: FerroKin rounds up $12M for iron overload treatment - FierceBiotech http://www.fiercebiotech.com/story/ferrokin-rounds-12m-iron-overload-treatment/2010-06-18?utm_medium=rss&utm_source=rss#ixz (fiercebiotech.com) [edit]
  20. Endocyte, Inc.: Series C $26M (onbiovc.com) [edit]
  21. PrimeraDx, Inc.: Series C $20M (onbiovc.com) [edit]
  22. XDx, Inc.: Series G $14.4M (onbiovc.com) [edit]
  23. Osage University Partners Source [edit]
  24. XDx raises $14.4M new funding (sanjose.bizjournals.com) [edit]
  25. Khosla Invests Still More In Biofuels: HCL CleanTech (earth2tech.com) [edit]
  26. Aerovance inhales $38M for asthma drugs (venturebeat.com) [edit]
  27. Catalyst Biosciences Raises $40 Million in Series C Financing (fiercebiotech.com) [edit]
  28. Gevo raises another $17M for synthetic biofuels (venturebeat.com) [edit]
  29. NanoVasc Funding (venturebeatprofiles.com) [edit]
  30. Light Sciences beams up $30M (venturebeat.com) [edit]
  31. Aerovance, asthma treatment company, finishes raising $60M (venturebeat.com) [edit]
  32. DiaDexus Raises $40M Series E For Expansion (scalevp.com) [edit]
  33. Neurotechâ„¢, Inc. Completes $35 Million Private Equity Financing (neurotechusa.com) [edit]
  34. EDGAR [edit]
  35. EDGAR [edit]
  36. CATALYST BIOSCIENCES RAISES $30 MILLION SERIES B FINANCING TO ADVANCE THERAPEUTIC PROTEASES (catalystbiosciences.com) [edit]
  37. Adlyfe Inc. Kicks Off 2006 With a $3.3M Series A Round (dc.citybizlist.com) [edit]
  38. XDx Completes $26.5 Million Private Equity Financing (xdx.com) [edit]
  39. Chlorogen closing in on $6 million funding round (bizjournals.com) [edit]
Edit This Page
Last Edited 4/17/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy